ertapenem sodium
Drug ingredientCAS 153773-82-1
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
18 FDA-registered drug labelers
Apotex Corp
Aurobindo Pharma Limited
BluePoint Laboratories
Dr.Reddys Laboratories Inc.,
ENDO USA, Inc.
Eugia US LLC
Fosun Pharma USA Inc
Fresenius Kabi USA, LLC
Gland Pharma Limited
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme LLC
NorthStar RxLLC
Qilu Antibiotics Pharmaceutical Co., Ltd.
Sagent Pharmaceuticals
Savior Lifetec Corporation
WG Critical Care, LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Ertapenem Sodium
- •Ertapenem
- •Invanz
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS153773-82-1
PubChem CID23674512
DTXSIDDTXSID50934806
FormulaC22H24N3NaO7S
Mol. Weight497.5 g/mol
SMILESCC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)[O-])C(=O)O)C(C)O.[Na+]
Data Sources
- PubChem · compound 23674512Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
ertapenem sodium (CAS 153773-82-1) https://chemicalindependence.com/chemical/153773-82-1/ PubChem: 23674512. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/23674512 FDA National Drug Code directory: CAS 153773-82-1. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/